While the top players of the over Rs850 billion pharmaceutical business are up
in arms over what they call rampant spread of counterfeit drugs (allegedly 20%
to 25% of total pharmaceutical sales) in the country, enforcement agencies and
some pharmaceutical associations say the situation is not that alarming,
reports PTI.
But, they acknowledged that there are areas, which have slowly...
